Sukumar Nagendran - President and Head of R&D, Director at Taysha Gene Therapies, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and Head of R&D, Director
Stock Symbol
TSHA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Sukumar Nagendran - trading volume in the past year for Taysha Gene Therapies, Inc.

Holdings reported by Sukumar Nagendran for Taysha Gene Therapies, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.01M $4.54M $4.51 Dec 1, 2025 Direct
Employee Stock Option (right to buy) 564K Dec 1, 2025 Direct Common Stock

Transactions reported by Sukumar Nagendran for Taysha Gene Therapies, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.